XT
MGRX icon

XTX Topco’s Mangoceuticals MGRX Stock Holding History

XTX Topco’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.73K Buy
+13,142
New +$6.3K ﹤0.01% 3754
2025
Q4 		– Sell
-28,514
Closed -$62.4K – 3604
2025
Q3 		$62.4K Buy
+28,514
New +$53.1K ﹤0.01% 2126
2024
Q4 		– Sell
-1,922
Closed -$6.8K – 2690
2024
Q3 		$6.8K Buy
+1,922
New +$9.07K ﹤0.01% 1960
2024
Q2 		– Sell
-1,623
Closed -$5.36K – 2230
2024
Q1 		$5.36K Buy
+1,623
New +$6.46K ﹤0.01% 1716

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

XTX Topco's MGRX Position: Q1 2026 in Review

XTX Topco opened a new position in Mangoceuticals (MGRX) in Q1 2026: 13,142 shares worth $4.73K. The stake represents ﹤0.01% of the portfolio and ranks #3754 among its holdings. This is a return to the name: XTX Topco previously reported a position in MGRX as recently as Q3 2025.

XTX Topco first reported a position in MGRX in Q1 2024 and has held it in 4 quarters since. The position peaked at $62.4K in Q3 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q1 2026.

  • XTX Topco held 13,142 shares of Mangoceuticals worth $4.73K as of Q1 2026.
  • Mangoceuticals was a new XTX Topco position in Q1 2026.
  • Mangoceuticals made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3754 holding.
  • XTX Topco first reported a position in Mangoceuticals in Q1 2024 and has held it in 4 quarters since.
  • XTX Topco's Mangoceuticals position peaked at $62.4K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.